PPW
TCRT icon

Pasadena Private Wealth’s Alaunos Therapeutics TCRT Stock Holding History

Pasadena Private Wealth’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-71
Closed -$6.67K – 126
2023
Q1 		$6.67K Hold
71
– – ﹤0.01% 106
2022
Q4 		$6.88K Hold
71
– – ﹤0.01% 103
2022
Q3 		$18K Hold
71
– – 0.01% 88
2022
Q2 		$13K Hold
71
– – ﹤0.01% 89
2022
Q1 		$7K Hold
71
– – ﹤0.01% 98
2021
Q4 		$12K Hold
71
– – ﹤0.01% 112
2021
Q3 		$19K Buy
+71
New +$21.7K 0.01% 92

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return